UMDNJ-Robert Wood Johnson Medical School is a clinical research site located in New Brunswick, New Jersey, United States 08903.
Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.
UMDNJ-Robert Wood Johnson Medical School has participated in 22 clinical trials.
Therapeutic areas: Suspected Heparin-Induced Thrombocytopenia, Osteoporosis, Progressive Supranuclear Palsy.
Sponsors: Canyon Pharmaceuticals, Inc., Novartis Pharmaceuticals, Westat.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in New Brunswick
Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UMDNJ-Robert Wood Johnson Medical School has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UMDNJ-Robert Wood Johnson Medical School has 22 clinical trials on record. Their work covers Suspected Heparin-Induced Thrombocytopenia, Osteoporosis, Progressive Supranuclear Palsy.
UMDNJ-Robert Wood Johnson Medical School has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.